Observational Study: Improving Cancer Screenings in Your Community
This study is looking at how well a community program helps people get screened for breast, lung, and prostate cancer. It's called "Building on Trust" and focuses on reaching adults who might not otherwise get these important screenings. The study will look at how many people are reached, how effective the program is, and how well it can be put into practice and kept going. You might be able to join if you are an adult aged 18 or older, are seeking care at a community resource spot or emergency department, and meet specific age and health criteria for lung, breast, or prostate cancer screening. The study aims to understand and improve how these screenings are offered and used in your community.
- Study design
- This is an observational study with a planned enrollment of 200 participants. It will evaluate a community-based outreach initiative.
- What's involved
- Participants may be referred for definitive diagnosis based on cancer screening results and may engage in stakeholder focus groups to provide feedback.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed from enrollment to the end of a 3-month follow-up period, for a total of 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Mark Socinski, MD · PRINCIPAL_INVESTIGATOR · AdventHealth
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- The categorization of the RE-AIM model dimensions of Reach, Effectiveness, Adoption, Implementation, and Maintenance,From enrollment to the end of the 3 month follow-up for a total of 12 months
Reach will assess the percentage and characteristics of patients screened or excluded, as well as participant versus non-participant profiles. Effectiveness will measure the proportion of positive screens referred for confirmatory diagnostics and compare screening rates to Healthy People 2030 goals. Adoption will track provider education on breast, lung, and prostate cancer screening guidelines, uptake of screening practices, and staff engagement with navigation programs. Implementation will evaluate referrals to navigation, screening rates, and for positive screens: referral time, diagnostic barriers, treatment uptake, and clinical trial screening. Maintenance will examine primary outcomes at three months, progress toward HP2030 goals, attrition rates, and differences by patient characteristics.